Skip to main content

Spinal Muscular Atrophy clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for
  • Spinraza in Adult Spinal Muscular Atrophy

    open to eligible people ages 18-70

    This is a longitudinal, observational study of adult patients with genetically confirmed chromosome 5q SMA to examine the safety, tolerability, and effectiveness of SPINRAZA® (nusinersen) for up to 30 months.

    Orange, California and other locations